These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 7946680

  • 1. Chondroitin sulfate iron colloid-enhanced MR imaging in patients with hepatocellular carcinoma. Comparison with CT during arterial portography.
    Kamba M, Suto Y, Kato T.
    Acta Radiol; 1994 Nov; 35(6):570-5. PubMed ID: 7946680
    [Abstract] [Full Text] [Related]

  • 2. A study of chondroitin sulfate iron colloid as a liver specific MR contrast agent.
    Hussain MZ, Ohtomo K, Kachi K, Uchiyama G, Itai Y.
    Radiat Med; 1994 Nov; 12(1):1-5. PubMed ID: 8016397
    [Abstract] [Full Text] [Related]

  • 3. Chondroitin sulfate iron colloid as MR contrast agent in differentiation between hepatocellular carcinoma and adenomatous hyperplasia.
    Suto Y, Kato T, Matsuo T, Kamba M, Shimatani Y, Ohuchi Y, Nakamura K, Ohta Y.
    Acta Radiol; 1993 May; 34(3):226-9. PubMed ID: 8387803
    [Abstract] [Full Text] [Related]

  • 4. Correlation between chondroitin sulfate iron colloid-enhanced MR imaging and the histological grade of hepatocellular carcinoma.
    Suto Y, Kodama F, Kamba M, Ohta Y.
    Acta Radiol; 1995 Jan; 36(1):102-5. PubMed ID: 7833161
    [Abstract] [Full Text] [Related]

  • 5. Double contrast MR imaging with iron colloid and Gd-DTPA in cholangiocellular carcinoma.
    Suto Y, Shimatani Y, Kato T, Kamba M, Ohuchi Y, Kodama F, Kato T, Ohta Y.
    Acta Radiol; 1994 Nov; 35(6):632-3. PubMed ID: 7946691
    [Abstract] [Full Text] [Related]

  • 6. Detection of hepatocellular carcinoma in patients with cirrhosis: MR imaging versus angiographically assisted helical CT.
    Kanematsu M, Hoshi H, Murakami T, Inaba Y, Kim T, Yamada T, Kato M, Yokoyama R, Nakamura H.
    AJR Am J Roentgenol; 1997 Dec; 169(6):1507-15. PubMed ID: 9393154
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Time-course changes of contrast enhancement in iron colloid enhanced MRI in patients with hepatocellular carcinoma.
    Suto Y, Ametani M, Kamba M, Sugihara S.
    Br J Radiol; 1996 Mar; 69(819):201-5. PubMed ID: 8800862
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Preoperative detection of hepatocellular carcinoma: ferumoxides-enhanced mr imaging versus combined helical CT during arterial portography and CT hepatic arteriography.
    Choi D, Kim S, Lim J, Lee W, Jang H, Lee S, Lim H.
    AJR Am J Roentgenol; 2001 Feb; 176(2):475-82. PubMed ID: 11159099
    [Abstract] [Full Text] [Related]

  • 11. [Usefulness of superparamagnetic iron oxide particles in the detection of hepatocellular carcinoma by MR imaging].
    Hirohashi S, Uchida H, Ohimichi R, Kitano S, Tanaka M, Ohishi H.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Apr 25; 53(4):469-71. PubMed ID: 8388092
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Optimum conditions for iron colloid enhanced fast spin echo imaging in hepatocellular carcinoma.
    Sugihara S, Suto Y, Yoshida K.
    Br J Radiol; 1997 Aug 25; 70(836):791-7. PubMed ID: 9486042
    [Abstract] [Full Text] [Related]

  • 14. [Evaluation of multislice dynamic MR imaging of the whole liver].
    Inoue E, Kuroda C, Fujita M, Hosomi N, Kadota T, Narumi Y, Kuriyama K, Yoshioka H, Kasugai H, Sasaki Y.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Apr 25; 54(5):363-70. PubMed ID: 8190605
    [Abstract] [Full Text] [Related]

  • 15. CT and MR imaging of hepatocellular carcinoma.
    Bolog N, Andreisek G, Oancea I, Mangrau A.
    J Gastrointestin Liver Dis; 2011 Jun 25; 20(2):181-9. PubMed ID: 21725516
    [Abstract] [Full Text] [Related]

  • 16. [Usefulness of spiral CT in the detection of hypovascular, well-differentiated hepatocellular carcinoma].
    Fujita M, Kuroda C, Inoue E, Kumatani T, Hosomi N, Narumi Y, Kuriyama K, Kadota T, Kasugai H, Sasaki Y, Ishiguro S.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Mar 25; 56(4):155-9. PubMed ID: 8992449
    [Abstract] [Full Text] [Related]

  • 17. Hepatocellular carcinoma exhibiting a concentric structure of different histologic grades: evaluation by chondroitin sulfate iron colloid-enhanced MR imaging.
    Kamba M, Suto Y, Kodama F, Ohta Y, Kobayashi J, Horie Y, Kawasaki H.
    J Magn Reson Imaging; 1996 Mar 25; 6(2):406-8. PubMed ID: 8859586
    [Abstract] [Full Text] [Related]

  • 18. Sensitivity in detection of hypervascular hepatocellular carcinoma by helical CT with intra-arterial injection of contrast medium, and by helical CT and MR imaging with intravenous injection of contrast medium.
    Hori M, Murakami T, Oi H, Kim T, Takahashi S, Matsushita M, Tomoda K, Narumi Y, Kadowaki K, Nakamura H.
    Acta Radiol; 1998 Mar 25; 39(2):144-51. PubMed ID: 9529444
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Expression of vascular endothelial growth factor in hepatocellular carcinoma and the surrounding liver: correlation with MR imaging and angiographically assisted CT.
    Kanematsu M, Osada S, Amaoka N, Goshima S, Kondo H, Moriyama N.
    Abdom Imaging; 2006 Mar 25; 31(1):78-89. PubMed ID: 16317488
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.